FORT WORTH, Texas, May 22, 2015 /PRNewswire/ --
The North American neuromodulation market report defines and segments the concerned market with analysis and forecast of revenue. This market is expected to reach $4,854.4 million by 2019 at a CAGR of 10.5% from 2014 to 2019.
Browse through the TOC of North America Internal Neuromodulation Market for an analysis of industry trends and segments, with the help of various tables and figures.
Early buyers will receive 10% customization on this report.
Neuromodulation is defined as the use of technology to impact the nervous system by various processes such as therapeutic alteration, stimulation, modification, inhibition and so on. This is done with the help of implantable devices; these devices are usually neural stimulators and are used to treat various chronic and acute pain syndromes, dystonia, movement disorders and spasticity. There are various types of stimulators that are usually used to stimulate the spinal cord and brain. The types include the spinal cord stimulator, deep brain stimulator, gastric electrical stimulator, vagus nerve stimulator and sacral nerve stimulator.
With the increase in chronic neurological disorders like epilepsy, there has been a constant growth in the neuromodulation market. The other factors driving the neuromodulation market includes technological advancements and favoring reimbursement policies.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/9466950772-speak_to_analyst.html
The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. In terms of modality, the market is also categorized into internal and external modality. The countries covered in this report are the U.S., Canada, and Mexico.
This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it puts through a competitive landscape and company profiles of the key players in the market including major companies, which are part of neuromodulation markets.
The Global Neurostimulation/Neuromodulation Market is driven by aging population and associated diseases like Alzheimer's, epilepsy, spinal cord injury, and Parkinson's disease. The market value is expected to reach from $4,503.9 to $7,810.4 million from 2013 to 2018, at a CAGR of 11.60%.
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
SOURCE MicroMarket Monitor